scispace - formally typeset
D

Daniela Sieghart

Researcher at Medical University of Vienna

Publications -  39
Citations -  516

Daniela Sieghart is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 7, co-authored 17 publications receiving 236 citations.

Papers
More filters
Journal ArticleDOI

SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity.

TL;DR: In this article, SARS-CoV-2-specific T-cell responses were quantified by IFNγ enzyme-linked immunosorbent spot assays using the Elecsys Anti-SARS CoV2 S immunoassay against the receptor-binding domain (RBD) of the spike protein and neutralisation tests.
Journal ArticleDOI

Side-by-Side Comparison of Three Fully Automated SARS-CoV-2 Antibody Assays with a Focus on Specificity.

TL;DR: Differences in specificities for the anti-SARS-CoV-2 antibody assays by Abbott, Roche, and DiaSorin that have a significant impact on the positive predictive values of these tests are found.
Journal ArticleDOI

Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis

TL;DR: Among antibody positive individuals, RA patients were found having significantly more antibodies (≥3) than disease controls which generally showed one or two antibody species, allowing to better distinguish between RA and other rheumatic disorders, also in patients not showing antibodies in current routine diagnostics.
Journal ArticleDOI

Hydrogen sulphide decreases IL-1β-induced activation of fibroblast-like synoviocytes from patients with osteoarthritis.

TL;DR: Data suggest that H2S partially antagonizes IL‐1β stimulation via selective manipulation of the MAPkinase and the PI3K/Akt pathways which may encourage development of novel drugs for treatment of OA.
Posted ContentDOI

Side by side comparison of three fully automated SARS-CoV-2 antibody assays with a focus on specificity

TL;DR: Differences in specificities for the anti-SARS-CoV-2 antibody assays by Abbott, Roche, and DiaSorin that have a significant impact on the positive predictability of these tests are found.